Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism

CP D'Incal, KE Van Rossem, K De Man, A Konings… - Clinical …, 2023 - Springer
Background Individuals affected with autism often suffer additional co-morbidities such as
intellectual disability. The genes contributing to autism cluster on a relatively limited number …

The ADNP syndrome and CP201 (NAP) potential and hope

I Gozes - Frontiers in neurology, 2020 - frontiersin.org
Activity-dependent neuroprotective protein (ADNP) syndrome, also known as Helsmoortel-
Van Der Aa syndrome, is a rare condition, which is diagnosed in children exhibiting signs of …

m6A epitranscriptomic regulation of tissue homeostasis during primate aging

Z Wu, M Lu, D Liu, Y Shi, J Ren, S Wang, Y Jing… - Nature Aging, 2023 - nature.com
Abstract How N 6-methyladenosine (m6A), the most abundant mRNA modification,
contributes to primate tissue homeostasis and physiological aging remains elusive. Here …

Novel ADNP syndrome mice reveal dramatic sex-specific peripheral gene expression with brain synaptic and tau pathologies

G Karmon, S Sragovich, G Hacohen-Kleiman… - Biological …, 2022 - Elsevier
Background ADNP is essential for embryonic development. As such, de novo ADNP
mutations lead to an intractable autism/intellectual disability syndrome requiring …

Unexpected gender differences in progressive supranuclear palsy reveal efficacy for davunetide in women

I Gozes, G Shapira, A Lobyntseva… - Translational Psychiatry, 2023 - nature.com
Progressive supranuclear palsy (PSP) is a pure tauopathy, implicating davunetide,
enhancing Tau-microtubule interaction, as an ideal drug candidate. However, pooling …

A novel davunetide (NAPVSIPQQ to NAPVSIPQE) point mutation in activity‐dependent neuroprotective protein (ADNP) causes a mild developmental syndrome

I Gozes, S Shazman - European Journal of Neuroscience, 2023 - Wiley Online Library
NAP (NAPVSIPQ, drug candidate name, davunetide) is the neuroprotective fragment of
activity‐dependent neuroprotective protein (ADNP). Recent studies identified NAPVSIP as a …

NAP (Davunetide): the neuroprotective ADNP drug candidate penetrates cell nuclei explaining pleiotropic mechanisms

M Ganaiem, ND Gildor, S Shazman, G Karmon… - Cells, 2023 - mdpi.com
(1) Background: Recently, we showed aberrant nuclear/cytoplasmic boundaries/activity-
dependent neuroprotective protein (ADNP) distribution in ADNP-mutated cells. This …

PACAP and NAP: effect of two functionally related peptides in diabetic retinopathy

AG D'Amico, G Maugeri, G Musumeci… - Journal of Molecular …, 2021 - Springer
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a peptide involved in physio-
pathological processes of the eye. It exerts multiple effects directly through activation of its …

Neuroprotective effect of the PACAP-ADNP axis on SOD1G93A mutant motor neuron death induced by trophic factors deprivation

B Magrì, AG D'Amico, G Maugeri, G Morello… - Neuropeptides, 2023 - Elsevier
Amyotrophic lateral Sclerosis (ALS) is a neurodegenerative disease characterized by
progressive degeneration of motor neurons in the central nervous system. Mutations in the …

[HTML][HTML] ADNP prompts the cisplatin-resistance of bladder cancer via TGF-β-mediated epithelial-mesenchymal transition (EMT) pathway

Y Xie, S Zhu, J Zang, G Wu, Y Wen, Y Liang… - Journal of …, 2021 - ncbi.nlm.nih.gov
Activity-dependent neuroprotective protein (ADNP) is vital for embryonic development and
brain formation. Besides, the upregulated expression of ADNP enhances tumorigenesis in …